134 related articles for article (PubMed ID: 20879750)
1. “Locked onto the target”: increasing the efficiency of antagomirzymes using locked nucleic acid modifications.
Kaur H; Scaria V; Maiti S
Biochemistry; 2010 Nov; 49(44):9449-56. PubMed ID: 20879750
[TBL] [Abstract][Full Text] [Related]
2. Locked nucleoside analogues expand the potential of DNAzymes to cleave structured RNA targets.
Vester B; Hansen LH; Lundberg LB; Babu BR; Sørensen MD; Wengel J; Douthwaite S
BMC Mol Biol; 2006 Jun; 7():19. PubMed ID: 16753066
[TBL] [Abstract][Full Text] [Related]
3. Improved RNA cleavage by LNAzyme derivatives of DNAzymes.
Vester B; Lundberg LB; Sørensen MD; Babu BR; Douthwaite S; Wengel J
Biochem Soc Trans; 2004 Feb; 32(Pt 1):37-40. PubMed ID: 14748708
[TBL] [Abstract][Full Text] [Related]
4. The advantages of being locked. Assessing the cleavage of short and long RNAs by locked nucleic acid-containing 8-17 deoxyribozymes.
Donini S; Clerici M; Wengel J; Vester B; Peracchi A
J Biol Chem; 2007 Dec; 282(49):35510-8. PubMed ID: 17908692
[TBL] [Abstract][Full Text] [Related]
5. LNAzymes: incorporation of LNA-type monomers into DNAzymes markedly increases RNA cleavage.
Vester B; Lundberg LB; Sørensen MD; Babu BR; Douthwaite S; Wengel J
J Am Chem Soc; 2002 Nov; 124(46):13682-3. PubMed ID: 12431091
[TBL] [Abstract][Full Text] [Related]
6. Antagomirzymes: oligonucleotide enzymes that specifically silence microRNA function.
Jadhav VM; Scaria V; Maiti S
Angew Chem Int Ed Engl; 2009; 48(14):2557-60. PubMed ID: 19229913
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of LNA-modified DNAzymes targeting a single nucleotide polymorphism in the large subunit of RNA polymerase II.
Fluiter K; Frieden M; Vreijling J; Koch T; Baas F
Oligonucleotides; 2005 Dec; 15(4):246-54. PubMed ID: 16396619
[TBL] [Abstract][Full Text] [Related]
8. Multiplex PCR to assay the effect of nucleic acid-based inhibitors on prothrombin transcript level.
Böhl M; Schwenzer B
Chem Biol Drug Des; 2007 Mar; 69(3):212-5. PubMed ID: 17441907
[TBL] [Abstract][Full Text] [Related]
9. Gaining target access for deoxyribozymes.
Schubert S; Fürste JP; Werk D; Grunert HP; Zeichhardt H; Erdmann VA; Kurreck J
J Mol Biol; 2004 May; 339(2):355-63. PubMed ID: 15136038
[TBL] [Abstract][Full Text] [Related]
10. New transition-metal-dependent DNAzymes as efficient endonucleases and as selective metal biosensors.
Lu Y
Chemistry; 2002 Oct; 8(20):4589-96. PubMed ID: 12561102
[TBL] [Abstract][Full Text] [Related]
11. Nucleic acid sequence analysis using DNAzymes.
Cairns MJ; Sun LQ
Methods Mol Biol; 2004; 252():291-302. PubMed ID: 15017058
[TBL] [Abstract][Full Text] [Related]
12. Locked nucleic acid modified DNA enzymes targeting early growth response-1 inhibit human vascular smooth muscle cell growth.
Fahmy RG; Khachigian LM
Nucleic Acids Res; 2004; 32(7):2281-5. PubMed ID: 15107496
[TBL] [Abstract][Full Text] [Related]
13. Targeting insulin-like growth factor I with 10-23 DNAzymes: 2'-O-methyl modifications in the catalytic core enhance mRNA cleavage.
Fokina AA; Meschaninova MI; Durfort T; Venyaminova AG; François JC
Biochemistry; 2012 Mar; 51(11):2181-91. PubMed ID: 22352843
[TBL] [Abstract][Full Text] [Related]
14. LNA nucleotides improve cleavage efficiency of singular and binary hammerhead ribozymes.
Christiansen JK; Lobedanz S; Arar K; Wengel J; Vester B
Bioorg Med Chem; 2007 Sep; 15(18):6135-43. PubMed ID: 17624789
[TBL] [Abstract][Full Text] [Related]
15. [Progress in locked nucleic acid research].
Li SM; Xu X; Liang HP; Li L
Sheng Li Ke Xue Jin Zhan; 2003 Oct; 34(4):319-23. PubMed ID: 14992013
[TBL] [Abstract][Full Text] [Related]
16. Two DNAzymes targeting the telomerase mRNA with large difference in Mg2+ concentration for maximal catalytic activity.
Yuan BF; Xue Y; Luo M; Hao YH; Tan Z
Int J Biochem Cell Biol; 2007; 39(6):1119-29. PubMed ID: 17499543
[TBL] [Abstract][Full Text] [Related]
17. Target-site selection for the 10-23 DNAzyme.
Cairns MJ; Sun LQ
Methods Mol Biol; 2004; 252():267-77. PubMed ID: 15017056
[TBL] [Abstract][Full Text] [Related]
18. Developing fluorogenic RNA-cleaving DNAzymes for biosensing applications.
Ali MM; Aguirre SD; Mok WW; Li Y
Methods Mol Biol; 2012; 848():395-418. PubMed ID: 22315083
[TBL] [Abstract][Full Text] [Related]
19. A complex RNA-cleaving DNAzyme that can efficiently cleave a pyrimidine-pyrimidine junction.
Lam JC; Withers JB; Li Y
J Mol Biol; 2010 Jul; 400(4):689-701. PubMed ID: 20630470
[TBL] [Abstract][Full Text] [Related]
20. Locked nucleic acids: promising nucleic acid analogs for therapeutic applications.
Veedu RN; Wengel J
Chem Biodivers; 2010 Mar; 7(3):536-42. PubMed ID: 20232325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
